SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-18-003916
Filing Date
2018-10-10
Accepted
2018-10-10 14:12:54
Documents
2
Period of Report
2018-10-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1740
2 picchio_poa.htm EX-24.1 12698
  Complete submission text file 0001567619-18-003916.txt   15966
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARBUTUS BIOPHARMA CORP 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
Picchio Gaston (Reporting) CIK: 0001755014 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34949 | Film No.: 181115751